MEDICUS PHARMA LTD. Shareholders' Equity
MEDICUS PHARMA LTD. (MDCX) had Shareholders' Equity of -$1.76 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent -$1.76M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.33M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$67.55K.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$910.13K.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$1.76M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.33M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$67.55K 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$910.13K 10-Q · filed 2025-11-14 |
| 2024-12-31 | $3.13M 10-K · filed 2026-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |